EP0714663A3
(en)
*
|
1994-11-28 |
1997-01-15 |
Lilly Co Eli |
Potentiation of drug responses by serotonin 1A receptor antagonists
|
EA000856B1
(ru)
*
|
1995-07-24 |
2000-06-26 |
Эли Лилли Энд Компани |
Способ лечения синдрома дефицита внимания/гиперактивности
|
DE69607904T2
(de)
*
|
1995-08-16 |
2000-10-05 |
Eli Lilly And Co., Indianapolis |
Potenzierung von Serotonin-Wirkstoffresponz
|
ZA967892B
(en)
*
|
1995-09-21 |
1998-03-18 |
Lilly Co Eli |
Selective β3 adrenergic agonists.
|
US6075040A
(en)
|
1996-09-05 |
2000-06-13 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
EP0792649A1
(en)
*
|
1996-02-29 |
1997-09-03 |
Eli Lilly And Company |
Treatment of sleep disorders
|
US20060068001A1
(en)
*
|
1996-03-25 |
2006-03-30 |
Wyeth |
Extended release formulation
|
US20030215507A1
(en)
*
|
1996-03-25 |
2003-11-20 |
Wyeth |
Extended release formulation
|
US6274171B1
(en)
*
|
1996-03-25 |
2001-08-14 |
American Home Products Corporation |
Extended release formulation of venlafaxine hydrochloride
|
FR2746314B1
(fr)
*
|
1996-03-25 |
1998-06-12 |
Pf Medicament |
Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee
|
EP0818198A1
(en)
*
|
1996-07-09 |
1998-01-14 |
Lilly S.A. |
Potentiation of drug response by increasing serotonin availability
|
US5958429A
(en)
*
|
1996-08-16 |
1999-09-28 |
Eli Lilly And Company |
Potentiation of serotonin response
|
US5958965A
(en)
*
|
1996-08-27 |
1999-09-28 |
American Home Products Corporation |
4-aminoethoxy indoles
|
FR2752732B1
(fr)
*
|
1996-08-28 |
1998-11-20 |
Pf Medicament |
Forme galenique a liberation prolongee de milnacipran
|
EP0827746B1
(en)
|
1996-09-05 |
2002-04-03 |
Eli Lilly And Company |
Carbazole analogues as selective beta3 adrenergic agonists
|
US6087376A
(en)
*
|
1997-02-05 |
2000-07-11 |
University Of Kentucky Research Foundation |
Use of lobeline compounds in the treatment of central nervous system diseases and pathologies
|
US5830904A
(en)
*
|
1997-02-05 |
1998-11-03 |
University Of Kentucky Research Foundation |
Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders
|
FR2759290B1
(fr)
*
|
1997-02-13 |
2004-06-18 |
Pf Medicament |
Minalcipran pour le traitement de l'incontinence urinaire
|
FR2759906B1
(fr)
*
|
1997-02-21 |
2004-06-04 |
Pf Medicament |
Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques
|
US5776969A
(en)
*
|
1997-02-27 |
1998-07-07 |
Eli Lilly And Company |
Treatment of sleep disorders
|
US5910319A
(en)
*
|
1997-05-29 |
1999-06-08 |
Eli Lilly And Company |
Fluoxetine enteric pellets and methods for their preparation and use
|
GB9714675D0
(en)
*
|
1997-07-11 |
1997-09-17 |
Smithkline Beecham Plc |
Novel composition
|
AU736596B2
(en)
*
|
1997-07-25 |
2001-08-02 |
H. Lundbeck A/S |
Indole and 2,3-dihydroindole derivatives, their preparation and use
|
UA56257C2
(uk)
*
|
1997-09-23 |
2003-05-15 |
Елі Ліллі Енд Компані |
Спосіб лікування неадекватної визивної поведінки
|
JP2001517628A
(ja)
*
|
1997-09-23 |
2001-10-09 |
イーライ・リリー・アンド・カンパニー |
注意欠陥/多動障害の治療法
|
UA57107C2
(uk)
*
|
1997-09-23 |
2003-06-16 |
Елі Ліллі Енд Компані |
Спосіб лікування розладу поведінки
|
AU9692898A
(en)
*
|
1997-10-17 |
1999-05-10 |
Eli Lilly And Company |
Potentiation of pharmaceuticals
|
US6228864B1
(en)
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
US6037360A
(en)
*
|
1997-10-28 |
2000-03-14 |
Vivus, Incorporated |
Administration of 5-HT3 receptor antagonists to treat premature ejaculation
|
CO5011072A1
(es)
|
1997-12-05 |
2001-02-28 |
Lilly Co Eli |
Etanolaminas pirazinil substituidas como agfonistas de los receptores
|
US20030013740A1
(en)
*
|
1998-03-27 |
2003-01-16 |
Martin P. Redmon |
Stable dosage forms of fluoxetine and its enantiomers
|
US6500827B2
(en)
*
|
1998-05-08 |
2002-12-31 |
Pharmacia & Upjohn Company |
Drug combinations
|
AU764579B2
(en)
*
|
1998-05-08 |
2003-08-21 |
Pharmacia & Upjohn Company |
New drug combinations of a N.A.R.I., preferably reboxetine, and pindolol
|
AU4100699A
(en)
*
|
1998-05-28 |
1999-12-13 |
Sepracor, Inc. |
Compositions and methods employing r(-) fluoxetine and other active ingredients
|
FR2781671A1
(fr)
*
|
1998-07-28 |
2000-02-04 |
Synthelabo |
Compositions pharmaceutiques contenant un inhibiteur de la recapture de la serotonine et leur application en therapeutique
|
US6339106B1
(en)
|
1999-08-11 |
2002-01-15 |
Sepracor, Inc. |
Methods and compositions for the treatment and prevention of sexual dysfunction
|
US6331571B1
(en)
*
|
1998-08-24 |
2001-12-18 |
Sepracor, Inc. |
Methods of treating and preventing attention deficit disorders
|
US6974838B2
(en)
*
|
1998-08-24 |
2005-12-13 |
Sepracor Inc. |
Methods of treating or preventing pain using sibutramine metabolites
|
US6476078B2
(en)
*
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
SI1113797T1
(sl)
*
|
1998-09-15 |
2010-02-26 |
Lilly Co Eli |
Uporaba duloksetina pri zdravljenju fibromialgije
|
ATE305307T1
(de)
*
|
1999-07-01 |
2005-10-15 |
Pharmacia & Upjohn Co Llc |
Reboxetin zur behandlung von migränekopfschmerzen
|
US6399826B1
(en)
|
1999-08-11 |
2002-06-04 |
Sepracor Inc. |
Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
|
BR0014166A
(pt)
*
|
1999-09-03 |
2002-05-14 |
Lilly Co Eli |
Método de utilização de inibidores de reabsorção de serotonina seletivo de rápido ataque para tratamento de disfunção sexual
|
US7163949B1
(en)
|
1999-11-03 |
2007-01-16 |
Amr Technology, Inc. |
4-phenyl substituted tetrahydroisoquinolines and use thereof
|
RU2309953C2
(ru)
|
1999-11-03 |
2007-11-10 |
Эймр Текнолоджи, Инк. |
Арил- и гетероарилзамещенные тетрагидроизохинолины, фармацевтическая композиция и способ лечения на их основе
|
UA77650C2
(en)
|
1999-12-06 |
2007-01-15 |
Lundbeck & Co As H |
Use of serotonin reuptake inhibitor in combination with deramcyclane
|
GB0004003D0
(en)
*
|
2000-02-22 |
2000-04-12 |
Knoll Ag |
Therapeutic agents
|
US6683114B2
(en)
*
|
2000-03-07 |
2004-01-27 |
Eli Lilly And Company |
Treatment of psoriasis
|
GB2362826A
(en)
*
|
2000-06-02 |
2001-12-05 |
Lilly Co Eli |
A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
|
CA2415532C
(en)
*
|
2000-07-11 |
2010-05-11 |
Albany Molecular Research, Inc. |
Novel 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
|
DE10042412B4
(de)
*
|
2000-08-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
|
US20040030131A1
(en)
*
|
2000-10-04 |
2004-02-12 |
Martine Keenan |
Pharmaceutical compounds
|
US20060223824A1
(en)
*
|
2000-11-28 |
2006-10-05 |
Wyeth |
Serotonergic agents
|
US20060287335A1
(en)
|
2000-11-28 |
2006-12-21 |
Wyeth |
Serotonergic agents for treating sexual dysfunction
|
FR2817257B1
(fr)
*
|
2000-11-30 |
2009-03-20 |
Sanofi Synthelabo |
Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
|
US20050192220A1
(en)
*
|
2001-02-05 |
2005-09-01 |
Gevys Pharmaceuticas Ltd. |
Composition and method for potentiating drugs
|
US6833377B2
(en)
|
2001-02-05 |
2004-12-21 |
Gevys Pharmaceuticals Ltd. |
Composition and method for potentiating drugs
|
US6855729B2
(en)
*
|
2001-02-20 |
2005-02-15 |
Timothy G. Dinan |
Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
|
WO2002083631A1
(en)
*
|
2001-04-13 |
2002-10-24 |
Sepracor Inc. |
Methods of preparing didesmethylsibutramine and other sibutramine derivatives
|
US7034059B2
(en)
|
2001-07-02 |
2006-04-25 |
Sepracor Inc. |
Methods of using norfluoxetine
|
US20030087963A1
(en)
|
2001-09-13 |
2003-05-08 |
Senanayake Chris H. |
Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
US20040034101A1
(en)
*
|
2001-11-05 |
2004-02-19 |
Cypress Bioscience, Inc. |
Treatment and prevention of depression secondary to pain (DSP)
|
EP1482921A1
(en)
*
|
2002-02-12 |
2004-12-08 |
Cypress Bioscience, Inc. |
Methods of treating attention deficit/hyperactivity disorder (adhd)
|
CA2382419A1
(en)
*
|
2002-04-24 |
2003-10-24 |
Le Groupe Lysac Inc. |
Synergistic blends of polysaccharides as biodegradable absorbent materials or superabsorbents
|
MXPA05000566A
(es)
*
|
2002-07-24 |
2005-08-29 |
Cypress Bioscience Inc |
Tratamiento de depresion secundaria al dolor (dsp).
|
EP1558231A4
(en)
*
|
2002-10-03 |
2010-09-08 |
Cypress Bioscience Inc |
DOSAGE CLIMBING AND FRICTIONAL DAILY DOSE OF ANTIDEPRESSANTS TO TREAT NEUROLOGICAL DISORDERS
|
US7704527B2
(en)
*
|
2002-10-25 |
2010-04-27 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
ES2310715T3
(es)
*
|
2003-02-14 |
2009-01-16 |
Pierre Fabre Medicament |
Uso del enantiomero (1s,2r) del milnacipran para la preparacion de un medicamento.
|
FR2851163B1
(fr)
*
|
2003-02-14 |
2007-04-27 |
|
Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
|
GB0309440D0
(en)
*
|
2003-04-25 |
2003-06-04 |
Lilly Co Eli |
Quinolone derivatives
|
US20040265373A1
(en)
*
|
2003-06-27 |
2004-12-30 |
David Wynn |
Soft tablet containing high molecular weight cellulosics
|
US20040265372A1
(en)
*
|
2003-06-27 |
2004-12-30 |
David Wynn |
Soft tablet containing high molecular weight cellulosics
|
AR047553A1
(es)
|
2003-07-04 |
2006-01-25 |
Lundbeck & Co As H |
La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
|
US20050226923A1
(en)
*
|
2004-04-07 |
2005-10-13 |
Gassert Chad M |
Venlafaxine compositions in the form of microtablets
|
KR101412339B1
(ko)
*
|
2004-07-15 |
2014-06-25 |
알바니 몰레큘라 리써치, 인크. |
아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를차단하기 위한 용도
|
US20060111393A1
(en)
*
|
2004-11-22 |
2006-05-25 |
Molino Bruce F |
4-Phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
|
US20060111394A1
(en)
*
|
2004-11-22 |
2006-05-25 |
Molino Bruce F |
Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
|
US20060111385A1
(en)
*
|
2004-11-22 |
2006-05-25 |
Molino Bruce F |
Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
|
US20070027162A1
(en)
*
|
2005-03-01 |
2007-02-01 |
Wyeth |
Crystalline and amorphous 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin -1-yl]-propyl}-N-pyridin-2-yl-benzamide hydrochloride
|
CN101495184A
(zh)
*
|
2005-07-15 |
2009-07-29 |
Amr科技公司 |
芳基和杂芳基取代的四氢苯并氮杂及其在阻断去甲肾上腺素多巴胺和血清素的重摄取中的应用
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
BRPI0720958A2
(pt)
*
|
2006-12-27 |
2014-03-18 |
Lek Pharmaceuticals |
Omposição de duloxetina
|
AR071997A1
(es)
*
|
2008-06-04 |
2010-07-28 |
Bristol Myers Squibb Co |
Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
|
US9156812B2
(en)
|
2008-06-04 |
2015-10-13 |
Bristol-Myers Squibb Company |
Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
|
US8815894B2
(en)
*
|
2009-05-12 |
2014-08-26 |
Bristol-Myers Squibb Company |
Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
|
CA2760837C
(en)
|
2009-05-12 |
2018-04-03 |
Albany Molecular Research, Inc. |
7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
|
US9034899B2
(en)
|
2009-05-12 |
2015-05-19 |
Albany Molecular Research, Inc. |
Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
|
US8865937B2
(en)
*
|
2009-11-06 |
2014-10-21 |
Mahendra G. Dedhiya |
Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamide
|
US9045468B2
(en)
|
2010-08-17 |
2015-06-02 |
Albany Molecular Research, Inc. |
2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
|
EP2959904A1
(en)
|
2014-06-27 |
2015-12-30 |
Institut De Recerca Contra La Leucemia Josep Carreras |
Methods for treating, diagnosing and prognosing a haematological malignancy
|
EP3348266A1
(en)
|
2017-01-16 |
2018-07-18 |
Leukos Biotech, S.L. |
Combination therapy for treating cancer
|